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Abstract
Osteoarthritis (OA) is the most common form of arthritis and a major cause of disability. This study evaluates the association
in Caucasian populations of two single nucleotide polymorphisms (SNPs) mapping to the Human Leukocyte Antigen (HLA)
region and deriving from a genome wide association scan (GWAS) of knee OA in Japanese populations. The frequencies for
rs10947262 were compared in 36,408 controls and 5,749 knee OA cases from European-descent populations. rs7775228 was
tested in 32,823 controls and 1,837 knee OA cases of European descent. The risk (major) allele at rs10947262 in Caucasian
samples was not significantly associated with an odds ratio (OR) = 1.07 (95%CI 0.94 -1.21; p = 0.28). For rs7775228 the meta-
analysis resulted in OR= 0.94 (95%CI 0.81-1.09; p = 0.42) for the allele associated with risk in the Japanese GWAS. In Japanese
individuals these two SNPs are in strong linkage disequilibrium (LD) (r2 = 0.86) with the HLA class II haplotype DRB1*1502
DQA1*0103 DQB1*0601 (frequency 8%). In Caucasian and Chinese samples, using imputed data, these SNPs appear not to
be in LD with that haplotype (r2,0.07). The rs10947262 and rs7775228 variants are not associated with risk of knee OA in
European descent populations and they do not appear tag the same HLA class II haplotype as they do in Japanese
individuals.
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Introduction
Osteoarthritis (OA) is the most common form of arthritis and
the leading cause of physical disability among the elderly in
industrialized nations with severely impaired quality of life due to
pain and loss of joint functioning [1]. Knee OA is a complex
disease with a multi-factorial etiology which includes both genetic
and environmental factors [2]. Although OA is not an inflamma-
tory arthropathy, inflammation-related factors have been shown to
be implicated in the pathogenesis of OA [3]. A number of studies
have been carried out to determine the genetic determinants of
knee OA and a large scale Japanese genome-wide association scan
(GWAS) has identified two single nucleotide polymorphisms
(SNPs) mapping to the human leukocyte antigen (HLA) gene
region to be strongly associated with knee OA [4]. One of the
markers identified, rs7775228, mapped to the HLA class II gene
DQB1 and reached genomewide significant in Japanese samples
(OR=1.34 95% CI 1.21–1.49 p= 2.4361028) but showed no
evidence of association in combined European populations used
for replication in the same study (OR=0.93 95%CI 0.76–1.13).
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The other marker identified mapped to intron 1 of the
butyrophilin-like 2 gene (BTNL2) gene which has been implicated
in T-cell activation [4]. The major allele at rs10947262 was
significantly associated with increased risk of knee OA in the
Japanese discovery and replication samples combined (OR=1.32
95%CI 1.19–1.46; p= 6.761028). In the Caucasian samples in
that study this marker appeared to be associated in the same
direction (OR=1.29 95%CI 1.03–1.61 p= 0.025) and combining
both Japanese and Caucasian data rs10947262 achieved genome-
wide significance (defined as p#561028) [5] overall. A subsequent
study by Shi and co-workers tested the same two SNPs in a
Chinese case-control study and an Australian case-control study
but failed to find a significant association for these SNPs in either
group [6].
The proteins encoded by the classical HLA class I and class II
genes are highly polymorphic, have been implicated in the
pathogenesis of over 100 diseases, including arthropathies like
rheumatoid arthritis and systemic lupus erythematosus and play
an essential role in self/non-self immune recognition [7]. The
presence of activated T cells and Th1 cytokine transcripts in
chronic joint lesions of patients with OA suggest that T cells
contribute to chronic inflammation [8,9]. T cells and chondrocytes
have been reported to interact through cell surface molecules such
as HLA, CD4 or CD8 in OA [8] and proliferative responses of
peripheral blood T cells from patients with OA are substantially
higher than those of control T cells from normal donors [9]. These
observations support a possible role for HLA variation in genetic
susceptibility to OA in agreement with the results from the
Japanese GWAS. Therefore, we have aimed to investigate whether
we could confirm the role of the two variants identified in Japanese
and mapping to these important immune response molecules in
risk of knee OA in European descent populations.
Methods
Study cohorts
All the study subjects provided written informed consent to
participate. This research project was approved by the ethical com-
mittees at all participating institutions as follows: The deCODE
case-control study protocol was approved by the Data Protection
Authority of Iceland and the National Bioethics Committee of
Iceland. The Nottingham case-control and the GOAL study
protocols were approved by the research ethics committees of
Nottingham City Hospital and North Nottinghamshire, UK. The
Chingford study protocol was approved by the Guys & St Thomas’
Trust and Waltham Forest Trust ethics committees approved the
study protocol. The TwinsUK study protocol was approved by St
Thomas’ Hospital Research Ethics Committee. The Hertfordshire
Cohort Study protocol approval was obtained from East and North
Hertfordshire Ethics Committee. The Estonian Study protocol was
approved by the Ethics Committee of the University of Tartu.
1- deCODE case-control. A list of patients with OA of the
hand, knee and hip was obtained on the basis of patients’ records
at hospitals and health care centers in Iceland [10]. Controls were
individuals with no external signs of OA in any joint who did not
have a diagnosis of primary OA. For the present study there were
1068 knee OA cases, and 31,654 controls included.
2- Nottingham case-control. All cases had been referred to
hospital with symptomatic, clinically severe knee OA and the
majority had undergone unilateral or bilateral total knee replace-
ment (TKR) within the previous 5 years. Patients (aged 40–90)
were included if they had a diagnostic code of primary OA. Height
and weight were measured to calculate BMI. Pre-operative knee
radiographs [11] were scored for individual radiographic features
of OA by a single observer and graded 0–3 according to a
standard atlas using the Kellgren and Lawrence (K/L) grade for
the tibiofemoral compartment of each knee [12]. Self-reported
ethnicity was assessed by a nurse administered questionnaire and
only individuals of European descent were included in the gene-
tic study. Controls were unaffected sibs of joint replacement
probands, free from radiographic OA and over the age of 45.
Subjects aged 45–85 who had undergone intravenous urography
(IVU) in the same hospital were assumed to represent the average
genetic susceptibility of the general population and recruited as
unrelated controls. Further details are described elsewhere [13].
3- Genetics of Osteoarthritis and Lifestyle (GOAL)
study. Recruitment criteria were the same as for the Not-
tingham case-control study. Cases with clinically severe knee OA
were recruited from hospital orthopaedic surgery total knee
replacement (TKR) lists in the Nottingham area as previously
described [14]. Approval for recruitment was obtained from the
research ethics committees of Nottingham City Hospital and
North Nottinghamshire. Knee radiographs were examined to
confirm the diagnosis and to grade for changes of OA and scored
for individual radiographic features of OA by a single observer and
graded 0–3 according to a standard atlas using the K/L grade for
each knee joint [12].Only individuals of European descent were
included in the genetic study. Subjects aged 45–85 who had
undergone intravenous urography (IVU) in the same hospital were
recruited as controls and underwent clinical examination and
radiographs of the pelvis and both knees.
4- The Chingford Study. A prospective population-based
longitudinal cohort of women of European descent (assessed by
questionnaire) derived from the register of a large general practice
in North London, representative of the general UK population.
The study design and rationale are described elsewhere in detail
[15]. The K/L grade was scored for the tibiofemoral compartment
of each knee [12]. Controls were individuals from the population
with no knee OA.
5- The TwinsUK study cohort. A case-control substudy of
OA was derived from the TwinsUK Adult Twin Registry which is
a population-based sample of twins from the UK studying the
hereditary basis of a wide variety of age-related traits and diseases
(http:/www.twinsUK.ac.uk). These twins were recruited from the
general population. Only women participated in an X-ray study to
investigate the heritability of radiographic OA. From those
participating in such study, 348 unrelated Caucasian women
(only one twin from each pair) aged 55 at the time of the visit with
both a knee and a hip K/L,2 at both the femoro-acetabular and
tibio-femoral compartments were selected as controls for geno-
typing the present study. Cases were unrelated Caucasian women
from the same cohort with severe knee OA who had undergone
unilateral or bilateral or total knee replacement (n = 43). All sub-
jects included in this analysis were unrelated so that no adjustment
for relatedness was required.
6- The Hertfordshire Cohort Study. A large population-
based study. Details of the study design have been published
previously [16]. Ethical approval was obtained from East and
North Hertfordshire ethical committees and all participants gave
written informed consent. Weight bearing anteroposterior and
lateral semi-flexed radiographs of both knees were. Radiographs
were graded at the tibio-femoral and patello-femoral joints using a
standard atlas and the K/L score was determined [20]. A K/L
grade $2 was defined as definite OA. For consistency with the
other radiographic cohorts in this study, only data on the
tibiofemoral compartment has been included here.
7- The Estonian Study. A population based sample from the
Estonian towns of Elva and Vo˜ru (421 subjects), aged 32–55 years
HLA Class II and Knee OA in European Populations
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was recruited using primary care lists [17]. In addition 95
consecutive arthroscopy patients, with the same age range, were
recruited from the clinic. All subjects had standardised weight-
bearing antero-posterior radiographs of the tibiofemoral joint.
Joint space narrowing (JSN) and presence of osteophytes, were
graded independently by two radiologists using a grading system
(grades 0 –III) based on a line-drawing atlas [18]. The JSN and
osteophytes grades were then used it to derive K/L score.
Individuals with a K/L grade$2 were considered cases, otherwise
were classified as controls.
Genotyping
deCODE. The rs7775228 SNP was assayed with various
Illumina Bead Chips ( Infinium HumanHap300, HumanHap300-
Duo, humanCNV370-Duo, Human610-Quad, Human1M or
Human1M-Duo SNP chips) excluding all samples with a yield
,98% from the analysis. The SNP had a call rate of over 97% on
each of the chip types, a combined call rate of over 98% and did
not deviate from Hardy Weinberg equilibrium on any chip type.
The rs10947262 SNP was assayed with the Human1M or Hu-
man1M-Duo BeadChips (Illumina) on 1,148 individuals. Geno-
types into the 32,000 samples assayed with the other chip types
and used in this study were imputed into pre-phased samples
based on Icelandic training set as described in [19]. The
imputation method uses the same statistical model as that used
in the IMPUTE software [20]. The agreement between directly
genotyped genotypes and imputed genotypes was 99%.
Similar methods were applied to the public HLA and SNP
dataset in [21] to impute the most likely genotypes for rs10947262.
Genotyping in the samples from Hertforshire, Chingford,
Nottingham (GOAL), TwinsUK and Estonia was carried out by
Kbioscience Ltd, Hertfordshire UK. SNPs were genotyped using
the KASPar chemistry, which is a competitive allele-specific PCR
SNP genotyping system using FRET quencher cassette oligos (http:
//www.kbioscience.co.uk/genotyping/genotyping-chemistry.htm).
Statistical Analysis
Allelic odds ratios (OR) were calculated by comparing the
frequencies among cases and controls and the p-value was
computed using a Pearson’s chi-square test. In the absence of
inter-study heterogeneity we constructed a Mantel-Haenszel meta-
analysis of data from the samples to assess the overall evidence of
association. The assumption of heterogeneity for each analysis was
tested using the DerSimonian-Laird method [22] and heteroge-
neity was evaluated with Q-statistic and I2. Random effects models
were used only if evidence of heterogeneity was observed
(I2.20%). The R software version 2.10.1 was used (The R
Foundation for Statistical Computing http://www.r-project.org/).
Linkage disequilibrium was computed using Haploview v 4.2
(http://www.broadinstitute.org/haploview).
Results
Genetic Association Study
The characteristics of the data used for replication and the allele
frequencies at the SNPs under study are shown in Table 1. As is
common for polymorphisms within the HLA region we see
considerable variation within European populations [7].
We found no evidence for association with rs7775228 in the
Icelandic cohort nor overall combining data with the published
Australian [6], Spanish and Greek data [4] (figure 1A). The
overall odds ratio (OR) for the risk (major) allele in Caucasians is
0.94 (95%CI 0.81-1.09; p = 0.42; I2 = 26%), using a random-
effects model due to the value of heterogeneity being higher than
25%. Similar results were obtained however using a fixed-effects
meta-analysis (OR=0.94; 95%CI 0.81 -1.09; p= 0.27). The
confidence intervals for the odds ratio in combined Caucasian
samples do not overlap the confidence intervals in Japanese for this
SNP (OR=1.34 95% CI 1.21–1.49) and the effect of this SNP in
risk of knee OA is significantly different with p,1.261024
between these two ethnic groups.
Table 1. Characteristics of cases and controls of unpublished studies included in the analysis.
Study cohort n
Age yrs
mean (SD)
BMI kg/m2
mean (SD)
Females
(%)
Country
of origin
MAF%
rs7775228 (1)
MAF%
rs10947262 (2)
deCODE kneeOA 764 70.0 (7.3) 28.9 (4.9) 63.9% Iceland 10.9% 9.2%
controls 31,237 59.3 (20.7) 27.0 (5.3) 54.5% 9.8% 10.0%
Nottingham kneeOA 1,831 68.7 (8.9) 29.7 (5.4) 55.3% UK N/A 6.7%
controls 729 66.3 (7.4) 26.6(3.9) 57.4% 6.6%
GOAL kneeOA 1,584 68.5 (7.1) 30.7 (5.4) 46.9% UK N/A 6.4%
controls 745 62.6 (8.4) 27.1 (4.4) 49.9% 6.5%
Chingford kneeOA 254 66.4 (6.4) 28.4 (5.3) 100% UK N/A 4.9%
controls 531 63.2 (5.9) 26.2 (4.2) 100% 7.2%
TwinsUK kneeOA 41 65.9 (9.9) 27.1 (3.2) 100% UK N/A 9.8%
controls 349 67.6 (5.6) 25.2 (4.2) 100% 6.0%
Hertfodshire kneeOA 146 65.2 (2.6) 29.5 (5.1) 41.2% UK N/A 5.5%
controls 776 64.8 (2.7) 26.2 (3.8) 50.1% 6.8%
Estonia kneeOA 68 51.0 (6.0) 30.6 (5.7) 65.7% Estonia N/A 12.5%
controls 447 46.5 (6.2) 27.7 (5.2) 69.8% 8.9%
MAF= minor allele frequency.
(1) Minor allele =C, major allele = T.
(2) Minor allele = T, major allele =C.
doi:10.1371/journal.pone.0023371.t001
HLA Class II and Knee OA in European Populations
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23371
For rs10947262, which was originally reported to be associated
in combined Spanish and Greek samples in the same direction as
in Japanese cases, we also find overall no evidence of association
OR=1.07 (95%CI 0.94 -1.21; p= 0.28) for the allele associated
with risk in the initial study using a random effects model (I2 = 27%
p (Cochran’s Q) ,0.19) although in this case the odds ratios in
Japanese (OR=1.32 95%CI 1.19–1.46) and Caucasians are
overlapping.
Unlike rs7775228 where all genotypes were directly typed, the
genotypes for rs10947262 for the largest dataset (deCODE) were
imputed. Therefore we assessed whether the use of an imputed
dataset might be influencing our conclusions. Excluding the imputed
dataset we confirmed that there was no association between this
marker and knee OA having obtained an OR=1.06 (95%CI 0.91 -
1.24; p= 0.45) for the allele associated with risk in the initial study
using a random effects model (I2 = 37% p (Cochran’s Q) ,0.12).
We hypothesized that the initial association reported by the
Japanese group [4] might be due to a role of the BTLN2 locus
itself, represented by these two SNPs, in risk of OA. The statistical
power available in our study – including both published and new
data - to detect an association between rs7775228 and knee OA
was 80% for an odds ratio of 1.17 for a significance level a=0.05.
For rs10947262 an OR$1.12 is needed for a=0.05. Thus,
although it is widely known that initial reports tend to overestimate
genetic effect sizes, our study is powered to detect effects con-
siderably smaller than the initial report and for genomewide
significance, so much so as to be below the lower 95% CI from the
initial report in [4]. Given the lack of replication in Caucasians of
this association the hypothesis of a direct role of either of these
SNPs in risk of knee OA seems unlikely.
Alternatively, the genetic association detected might have
been due to linkage disequilibrium (LD) between rs7775228 and
Figure 1. Meta-analysis of genetic association between two HLA SNPs and knee OA. Forest plot of study-specific estimates and random-
effects summary effect size and 95% confidence intervals (95%CIs) for the genetic association with knee OA of (A) the major allele (T) at rs7775228 in
three published studies and the deCODE case-control study (B) the major allele (C) at rs10947262 in three published studies and seven additional
European studies. Square sizes are proportional to the number of cases in each study.
doi:10.1371/journal.pone.0023371.g001
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rs10947262 and classical HLA loci and the lack of replication
might be explained by differences in the pattern of LD across
ethnic groups, which in the case of HLA are well documented to
vary extensively even between ethnically similar populations (e.g.
Asian/Pacific populations [23]). We have therefore investigated
if the differences observed could be explained by differences in
LD between the initial population studied (Japanese) and the
subsequent replication samples of Chinese and Caucasian descent.
Linkage disequilibrium with classical HLA class II loci
De Bakker and co-workers [21] determined LD patterns
between the highly polymorphic HLA genes and background
variation by typing the classical HLA genes and .7,500 common
SNPs and deletion/insertion polymorphisms across four popula-
tion samples, including European descent and Japanese samples.
That analysis provided informative tag SNPs to capture some of
the variation in the MHC region and is publicly available online
(http://www.inflammgen.org/index.php?option=com_content&task
=view&id= 25&Itemid= 42). We used this database to investigate
which classical HLA genes are in LD with the two SNPs identified
by the Japanese study.
Among the Japanese samples included in this public domain
resource the minor allele at rs7775228 tags the HLA class II
haplotype DQA1-0103-DQB1*0601 which has a frequency of
17.05% in Japanese (r2 =0.38). Although rs10947262 was not
directly genotyped in the study by De Bakker et al [21], the large
amount of closely markers available in this set made it possible for us
to apply standard imputation methods [20] to impute the genotypes
for rs10947262 in this dataset for all three ethnic groups under study.
In Japanese samples the minor allele at rs10947262 is in positive
LD with DRB1*1502 with r2 = 0.512. DRB1*1502 has a
frequency of 10.05% in Japanese samples and is itself in LD with
DQA1-0103-DQB1*0601 (r2 = 0.27) in this ethnic group. The
haplotype formed by the minor alleles at rs7775228 and
rs10947262 (haplotype frequency 8.05%), which was found to be
more strongly associated in Japanese cases than either individual
marker, tags haplotype DRB1*1502 DQA1*0103 DQB1*0601
with r2 = 0.864 (Figure 2). Therefore, these two SNPs are tagging
a specific class II antigen presenting haplotype.
The DRB1*1502 DQA1*0103 DQB1*0601 HLA class II
haplotype is present in Caucasian samples in the public domain
HLA-SNP map set [21] in 3 out of 360 haplotypes (frequen-
cy = 0.8%). The LD with the minor allele at rs7775228 is
r2 = 0.060 and with rs10947262 is only r2 = 0.002. The haplotype
formed by the minor alleles at these two loci has an r2 = 0.003 with
DRB1*1502 DQA1*0103 DQB1*0601 (Figure 2). We further
confirmed that the frequency of the DRB1*1502 DQA1*0103
DQB1*0601 in Caucasians is very low in the literature in a large
study of Caucasian samples (derived from 606 pedigrees, 2424
individuals) where this haplotype was reported to have a frequency
of 0.7% [24].
In Han Chinese from Beijing (HCB) samples in the De Bakker
study [21] DRB1*1502 DQA1*0103 DQB1*0601 has a frequency
of 2.3% and the LD with rs7775228 is r2 = 0.058, r2 = 0.044 with
rs10947262 and r2 = 0.090 with the haplotype formed by the
minor alleles at both SNPs. (Figure 2). Therefore, in Chinese and
Caucasian samples these two SNPs are not tagging the HLA
DRB1-DQA1-DQB1 haplotype that they tag in Japanese samples.
Figure 2. Map of the HLA class II region in harboring markers rs7775228 and rs10947262. The frequency of haplotype DRB1*1502
DQA1*0103 DQB1*0601 and its linkage disequilibrium with rs7775228 and rs10947262 in three ethnic groups is shown.
doi:10.1371/journal.pone.0023371.g002
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Discussion
In this study we failed to find an association between markers
rs7775228 and rs10947262 and knee OA in European descent
samples in spite of a sample size large enough to have sufficient
statistical power to confirm the effect sizes previously reported and
even much more modest genetic effects. We could not replicate in
European descent samples the findings of Nakajima and co-
workers [4] who identified a genome-wide significant association
between these two SNPs and knee OA in Japanese subjects.
Furthermore, Shi et al [6] were unable to find an association in
Chinese OA patients for these same SNPs.
There have been several studies analyzing genomewide
significant variants directly across ethnicities with varying results
[25–26]. Because of differences in underlying LD structure and
variant frequency between ancestral populations the tagging
relationship between a SNP and a pathogenic variant may be
disrupted. Therefore a non-replication of a particular variant must
be considered inconclusive and warrant further investigation as
demonstrated in a recent study of breast cancer at the ESR1 locus
[27]. Having analyzed the LD between the two SNPs ( rs7775228
and rs10947262) identified by GWAS observation in the Japanese
study by Nakajima and co-workers [4] and the classical loci in the
HLA class II region, we can infer that the DRB1*1502
DQA1*0103 DQB1*0601 haplotype is protective for risk of OA
in Japanese samples. Thus, association of these two SNPs with OA
in the Japanese samples may be due to their property of tagging
this haplotype. The frequency of this HLA haplotype varies
between ethnic groups; it is present in 8% frequency in Japanese
samples, 2.3% in Chinese samples and is only in 0.7–0.8%
frequency in European samples. Moreover, the two SNPs are not
in LD with this haplotype in European or in Chinese samples,
possibly explaining the non-replication of these SNPs. A suitable
tag SNP for this particular DRB1-DQB1 haplotype in European
samples is rs2858880 [21] which has r2,1.0 with DRB1*1502
DQA1*0103 DQB1*0601. The minor allele at this SNP is very
rare and to achieve 80% power and p,0.05 even assuming a
strong protective effect (OR=0.7, i.e. non carriage of this
haplotype results in OR=1.4) it would require 10,586 knee OA
cases and 10,586 controls, i.e., almost twice as many cases as were
tested in our study. Ideally, however, the HLA loci should be
genotyped directly (e.g.using PCR-based sequence specific
oligonucleotide probe methods) in order to achieve conclusive
validation results and to assess the role of any other DRB1-DQA1-
DQB1 haplotypes in risk of OA.
We note that there are some potential study limitations, in
particular the different definitions of knee OA used by the various
studies, some of which focus on total knee replacement as an
outcome and others that have focused on radiographic features
and for OA phenotypic definitions which reflect a different subset
of OA have been shown to influence the ability to detect genetic
associations [28]. The initial discovery was made in Japanese
samples using a definition of radiographic OA (K/L$2) and pain
[4]. The association with rs10947262 initially was replicated in a
Greek study where the outcome as total knee replacement (TKR)
but the association with rs7775228 was not replicated in that same
cohort [4]. In fact, rs7775228, the Icelandic, Spanish and Greek
studies all used TKR as the outcome and show no evidence of
association. For rs10947262 we cannot distinguish a clearly
different pattern for studies where only a radiographic definition
was used (e.g. Chingford, TwinsUK, HCS, Estonia) from those
where symptoms or even TKR were part of the recruitment
criterion (e.g. Nottingham, GOAL, deCODE). Further, for knee
OA it has been shown in a case where the functional variant of a
gene is truly involved in risk of disease (the promoter variant in the
GDF-5 gene) that, these differences in phenotype definition do not
deter from observing an association in Caucasians with genome-
wide statistical significance even if it had been originally
discovered in Asian samples [29].
Another study limitation to our conclusions is that the data used
to derive inferences concerning LD with HLA haplotypes comes in
part from imputed data. Therefore, although imputation for this
SNP appears to be reliable, it is unlikely but possible that the
conclusions might have been different using directly typed data.
Neither our results nor those from Shi et al [6] preclude an
important role for variation in the HLA region in genetic
susceptibility to OA. It is indeed possible that class II antigen
presenting molecules may be involved in the pathogenesis of OA.
In order to determine if DRB1 -DQA1-DQB1 haplotypes (and
antigen presenting molecules in general), are involved in risk of
knee OA in Caucasian populations, further studies which take into
account the complex LD structure and the extremely high genetic
diversity of this region are needed.
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